---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-032947"
form_type: "8-K"
ticker: "PASG"
cik: "0001787297"
company_name: "Passage BIO, Inc."
filed_at: "2022-03-11T23:59:59+00:00"
generated_at: "2026-06-26T23:39:57.229449+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Passage Bio director Liam Ratcliffe resigns over disagreement on business plans

## Summary
- Liam Ratcliffe, MD, Ph.D., resigned from the Board and its Nominating and Governance Committee, effective March 7, 2022.
- Resignation cited a disagreement with the company regarding its business plans and operations.
- No replacement announced; Board size reduced.

## SEC filing metadata
- accession: 0001104659-22-032947
- form_type: 8-K
- ticker: PASG
- cik: 0001787297
- company_name: Passage BIO, Inc.
- filed_at: 2022-03-11T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1787297/000110465922032947/0001104659-22-032947-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1787297/000110465922032947/tm228940d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-032947
- JSON: https://secwatch.observer/filing/0001104659-22-032947.json
- Plain text: https://secwatch.observer/filing/0001104659-22-032947.txt

## Key facts
- Executive change
  Liam Ratcliffe resigned as Director at Passage BIO, Inc..
  - Action: resigned
  - Role: Director
  source text: On March 7, 2022, Liam Ratcliffe, MD, Ph.D., notified Passage Bio, Inc. (the “Company”) of his decision to resign from the Company’s Board of Directors (the “Board”), including from the Nominating and Governance Committee of the Board, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1787297/000110465922032947/0001104659-22-032947-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.